Joshua Patterson
Responsabile della Conformità presso CG ONCOLOGY, INC.
Patrimonio netto: 5 078 $ in data 30/04/2024
Profilo
Joshua F.
Patterson served as the Executive Director & Deputy General Counsel at Ionis Pharmaceuticals, Inc. from 2006 to 2018.
Prior to that, he worked as In-House Counsel at Amylin Pharmaceuticals, Inc. from 2000 to 2006.
He then joined Akcea Therapeutics, Inc. as the Secretary & Vice President-Legal from 2018 to 2020.
Currently, he is the Chief Compliance Officer & General Counsel at Gamida Cell Ltd.
starting from 2021 until 2024.
Mr. Patterson completed his undergraduate degree at Carthage College and his graduate degree at Syracuse University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
GAMIDA CELL LTD.
0.18% | 15/03/2024 | 282 096 ( 0.18% ) | 5 078 $ | 30/04/2024 |
Posizioni attive di Joshua Patterson
| Società | Posizione | Inizio |
|---|---|---|
| CG ONCOLOGY, INC. | Responsabile della Conformità | 01/05/2024 |
Precedenti posizioni note di Joshua Patterson
| Società | Posizione | Fine |
|---|---|---|
| GAMIDA CELL LTD. | Responsabile della Conformità | 26/04/2024 |
| IONIS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/03/2018 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/09/2006 |
| AKCEA THERAPEUTICS, INC. | Consigliere Generale | - |
Formazione di Joshua Patterson
| Carthage College | Undergraduate Degree |
| Syracuse University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| GAMIDA CELL LTD. | Health Technology |
| CG ONCOLOGY, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Joshua Patterson
